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Among the ANS heart failure model mice, a cardiac function analysis group and a kidney function analysis group were prepared. Echocardiography and urine collection were performed at 2 weeks and 4 weeks after the intervention. Systolic blood pressure was measured weekly after the intervention. The sample materials such as plasma, myocardium, right kidney, lung, aorta, and liver tissue, were collected under general anesthesia by using pentobarbital.
Physiological analysis
Systolic blood pressure was measured in conscious mice by the tail-cuff method (BP-98a, Softron, Tokyo, Japan) as described previously (4, 5) .Echocardiography was performed with a Vevo 2100 High-Resolution Imaging System (Visual Sonics Inc, Toronto, Ontario, Canada) equipped with a 40-MHz transducer, and measured at 2 and 4 weeks after the ANS treatment. Mice were anesthetized with general anesthesia using isoflurane for animal inhalation (DS Pharma Animal Health, Osaka, Japan) adjusting the depth of anesthesia to 50-70 respirations/min. Short -axis M-mode images were recorded at the papillary muscle level. After measurement, software analysis was performed to calculate the left ventricular inner diameter contraction ratio (percentage left ventricular fractional shortening; LVFS). The calculations were performed on three different points in time of each mouse.
Urine collection
Urine was collected for 3 days before the ANS treatment, and then 2 and 4 weeks after the ANS intervention from mice using metabolic cages. Urine volume was measured, and then 1 mL of the urine was collected. The dispensed urine was centrifuged at 10,000 rpm, then urine samples were collected and stored at -80˚C until use.
Kidney function analysis
For the functional analysis of the kidney, creatinine clearance (Ccr) was measured as an indicator of glomerular filtration rate at 4 weeks after ANS intervention. Urinary creatinine was quantified by creatinine test kit (#290-65901, FUJIFILM Wako Pure Chemical Co., Osaka, Japan) at 4 weeks after ANS intervention. Plasma creatinine was measured using Fuji Dri-Chem System (FDC 7000 V, FUJIFILM Co., Tokyo, Japan).
Ccr was calculated from plasma creatinine (Scr), urinary creatinine (Ucr), urine volume (Uv), and body surface area (BSA) using the following reduction formula. 9.822 for C57BL/6J (6) was applied as the Meeh constant k (7) . The urinary albumin was measured for each urine sample at the point before the ANS intervention, 2 weeks and 4 weeks after intervention by Rebis albumin mouse ELISA kit (#AKRAL-121, FUJIFILM Wako Shibayagi Co., Gunma, Japan), and the daily excretion of urinary albumin was calculated from the urinary albumin concentration and urine 6 volume. The urinary NGAL was measured for each urine sample at the time point before the ANS intervention, 2 weeks and 4 weeks after intervention. All assays were conducted using a Mouse Lipocalin-2/NGAL Quantikine ELISA kit (#MLCN20, R&D Systems, Inc., MN, USA) according to the instructions of the manufacturer. The urine from each mouse was 100-fold diluted and 50 µL of each sample were used for quantification of NGAL levels in urine. The daily excretion of NGAL was calculated from the urinary NGAL concentration and urine volume. Urinary β-2 microglobulin was measured at 4 weeks after intervention. All assays were conducted using a Mouse Beta-2-Microglobulin (b2M) ELISA kit (#RK0627, ABclonal Technology, Inc., MA, USA) according to the instructions of the manufacturer. The urine was diluted 100 times and 100 µL of each sample were used for quantification. The daily excretion of β-2 microglobulin was calculated from the urinary β-2 microglobulin concentration and urine volume.
Histological analysis
The heart, kidney, lung, and aorta samples were harvested and fixed in 4% paraformaldehyde for 48 h at 4°C, washed with PBS, dehydrated, and embedded in paraffin. Tissues were sectioned into 5 µm thickness for H&E staining, 2 µm for Siriusred and Periodic acid-Schiff (PAS) staining using a rotary microtome (HM340E, Microm
International GmbH, Walldorf, Germany). After deparaffinization, H&E staining for lung and aorta section was performed as described previously (8) . Cardiac and renal sections were stained with Sirius-red for the detection of fibrosis using Picro-Sirius Red Stain Kit (#PRS-1-IFU, ScyTek, Utah, USA) by standard procedure. Briefly, deparaffinized 2-µ thick sections were hydrated to distilled water, placed in Picro-Sirius Red solution for 60 min. Then, rinsed in two changes of 0.5% acetic acid and dehydrated with absolute alcohol, cleared, and mounted. Renal sections were also stained with PAS to observe the pathological changes in tubules and glomeruli by standard procedure. Data images were obtained using a BZ-X800 microscope (KEYENCE Co., Osaka, Japan), BX53 microscope with polarizing filter, and a DP21 digital camera (Olympus, Tokyo, Japan).
Three to five mice per each group were used for histological analysis. The area of fibrosis was defined as birefringence part of section under the polarized light microscopy, and ten fields per one section were measured, then ratio of the fibrosis area was calculated. In kidney, fibrosis area of glomerular and perivascular part was measured separately, and diameter of glomeruli was measured from thirty glomeruli per a mouse. The fibrosis area and diameter of glomeruli were measured using ImageJ 1.52k software (http://imagej.nih.gov/ij/).
Transmission electron microscopy
For ultrastructure analysis, kidney tissues were perfused with 2% glutaraldehyde/2% paraformaldehyde, then dissected, following immersion fixation in 2.5% glutaraldehyde in 0.1 M phosphate buffer. The kidney tissue was then processed as per standard procedure, and ultrathin sections were subjected to transmission electron microscopy analysis with a JEM-1,400 electron microscope (JOEL, Tokyo, Japan) at the electron microscopy facility at University of Tsukuba. For TEM analysis, multiple numbers of sections from three mice per each group were analyzed.
Sample processing for LC-MS/MS analysis
One nmol of d4-histamine (dihydrochloride salt of histamine-α, α, β, β-d4 obtained from C/D/N isotopes (Quebec, Canada)) was added to 100 μl of plasma as an internal standard. After adding 400 μl of methanol and 100 μl of chloroform, the mixture was vortexed and Milli-Q water was added up to 0.9 ml. The sample was mixed and centrifuged at 13,000 g for 10 min at 4°C. Deproteinized samples were subjected to crude fractionation on a MonoSpin SCX column and centrifuged at 5,800 g for 1 min The column was washed with 300 µL of 0.1 formic acid in methanol followed by 300 µL of 100% methanol. Next, the column was set in a fresh recovery tube, and extracts were eluted from the column into the recovery tube with 300 µL of elution solvent (25% NH3:methanol = 1:4, v/v) via centrifugation at 5,800 g for 1 min. Eluted fractions were dried with EYELA Centrifugal vaporizer (Tokyo-Rika, Tokyo, Japan). The dried powder was dissolved with 100 µL of 50% acetonitrile in 0.1% formic acid. The insoluble matter was removed by centrifugation at 13,000 g for 5 min. The supernatant was stored until the LC-MS/MS analysis at -20°C.
LC-MS/MS analysis of plasma histamine
Plasma histamine was quantified using a Shimadzu Nexera TM ultra high-pressure
liquid chromatography system coupled with a LCMS-8050 TM triple quadruple mass spectrometer (Shimadzu, Kyoto, Japan) as described previously (9) All analyses and data processing were completed with the LabSolutions Ver. 5.60 software (Shimadzu Scientific Instruments, Inc., Columbia, MD).
RNA analysis
The kidneys, hearts, and livers were harvested and frozen in liquid nitrogen and then stored in a deep freezer until use. Frozen tissues were crushed into a powder with a Multi Bead Shocker (Yasui Kikai Co., Osaka, Japan). From a subset of the tissue powder,
Transcriptome analysis
For RNA sequencing analysis of kidney and heart tissues, total RNA was extracted by ISOGEN II (Nippon Gene., Ltd., Tokyo, Japan 
Measurement of serum amyloid A in plasma
Serum amyloid A in plasma was measured by using the mouse SAA ELISA Kit (#KMA0021, Thermo Fisher Scientific, Waltham, MA, USA) according to the manufacturer's instructions.
Measurement of C-reactive protein in plasma
C-reactive protein in plasma was measured by using the Mouse C-Reactive Protein/CRP Quantikine ELISA Kit (#MCRP00, R&D Systems, Inc., MN, USA)
according to the manufacturer's instructions.
Measurement of blood urea nitrogen (BUN) in plasma
Plasma BUN was measured by using Fuji Dri-Chem System (FDC 7000 V, FUJIFILM Co., Tokyo, Japan), according to the manufacturer's instructions.
Measurement of Cystatin C in plasma
Cystatin C in plasma was measured by using the Mouse/Rat Cystatin C Quantikine ELISA Kit (#MSCTC0, R&D Systems, Inc., MN, USA) according to the manufacturer's instructions.
Statistical analysis
All statistical analyses were performed using GraphPad Prism 8 for Mac (GraphPad Software Co, CA, USA). The number of animals is shown in each figure legend. The
Mann-Whitney U test, Welch's t-test, Student's t-test, one-way ANOVA followed by Tukey's multiple comparison test, or one-way ANOVA followed by Dunnett's multiple comparison test were used. Results with P < 0.05 were considered statistically significant.
Supporting figure legends:
SI Appendix, Fig. S1 . Cardiorenal damages in ANS mice. 
